Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $6.53 billion. The enterprise value is $6.86 billion.
| Market Cap | 6.53B |
| Enterprise Value | 6.86B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 64.93 million shares outstanding. The number of shares has increased by 15.36% in one year.
| Current Share Class | 64.93M |
| Shares Outstanding | 64.93M |
| Shares Change (YoY) | +15.36% |
| Shares Change (QoQ) | +7.69% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 98.83% |
| Float | 56.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.57 |
| Forward PS | 8.74 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86
| Current Ratio | 2.86 |
| Quick Ratio | 2.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.16 |
Financial Efficiency
Return on equity (ROE) is -702.97% and return on invested capital (ROIC) is -9.07%.
| Return on Equity (ROE) | -702.97% |
| Return on Assets (ROA) | -6.79% |
| Return on Invested Capital (ROIC) | -9.07% |
| Return on Capital Employed (ROCE) | -11.70% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | -$1.99M |
| Employee Count | 433 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 4.64 |
Taxes
In the past 12 months, MIRM has paid $2.67 million in taxes.
| Income Tax | 2.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.50% in the last 52 weeks. The beta is 0.51, so MIRM's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +54.50% |
| 50-Day Moving Average | 109.99 |
| 200-Day Moving Average | 93.93 |
| Relative Strength Index (RSI) | 41.30 |
| Average Volume (20 Days) | 748,825 |
Short Selling Information
The latest short interest is 6.82 million, so 10.51% of the outstanding shares have been sold short.
| Short Interest | 6.82M |
| Short Previous Month | 7.27M |
| Short % of Shares Out | 10.51% |
| Short % of Float | 12.09% |
| Short Ratio (days to cover) | 10.49 |
Income Statement
In the last 12 months, MIRM had revenue of $618.07 million and -$860.21 million in losses. Loss per share was -$15.34.
| Revenue | 618.07M |
| Gross Profit | 505.11M |
| Operating Income | -96.23M |
| Pretax Income | -857.54M |
| Net Income | -860.21M |
| EBITDA | -70.28M |
| EBIT | -96.23M |
| Loss Per Share | -$15.34 |
Balance Sheet
The company has $438.29 million in cash and $762.95 million in debt, with a net cash position of -$324.66 million or -$5.00 per share.
| Cash & Cash Equivalents | 438.29M |
| Total Debt | 762.95M |
| Net Cash | -324.66M |
| Net Cash Per Share | -$5.00 |
| Equity (Book Value) | -10.42M |
| Book Value Per Share | -0.16 |
| Working Capital | 413.52M |
Cash Flow
In the last 12 months, operating cash flow was -$227.27 million and capital expenditures -$1.47 million, giving a free cash flow of -$228.74 million.
| Operating Cash Flow | -227.27M |
| Capital Expenditures | -1.47M |
| Depreciation & Amortization | 25.95M |
| Net Borrowing | 672.44M |
| Free Cash Flow | -228.74M |
| FCF Per Share | -$3.52 |
Margins
Gross margin is 81.72%, with operating and profit margins of -15.57% and -139.18%.
| Gross Margin | 81.72% |
| Operating Margin | -15.57% |
| Pretax Margin | -138.75% |
| Profit Margin | -139.18% |
| EBITDA Margin | -11.37% |
| EBIT Margin | -15.57% |
| FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.36% |
| Shareholder Yield | -15.36% |
| Earnings Yield | -13.16% |
| FCF Yield | -3.50% |
Analyst Forecast
The average price target for MIRM is $138.21, which is 37.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $138.21 |
| Price Target Difference | 37.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 25.52% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 3 |